Concepedia

Morrison Jusu

MJ

4

Publications

225

Citations

4

H-Index

2017

Active since

Affiliations

University of Sierra Leone(Current)

Mwanza Intervention Trials Unit

Janssen (Belgium)

National Institute for Medical Research

London School of Hygiene & Tropical Medicine

Morrison Jusu is an author at University of Sierra Leone specializing in vaccination, epidemiology, and vaccine safety.

Top concepts

Publications per year

2017–2023

4

Publications

4

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 89 citations · Full text

, , +9

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 85 citations · Full text

, , +10

Rapid Establishment of a Cold Chain Capacity of –60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone

Morrison Jusu, Geoffrey Glauser, Jane F. Seward et al. · The Journal of Infectious Diseases · 2017 · 39 citations · Full text

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

E Choi, Boris Lacarra, Muhammed O. Afolabi et al. · The Lancet Global Health · 2023 · 12 citations · Full text

Rows per page

1–4 of 4